Industrial biotech specialist Ingenza announced that it is collaborating with clinical-stage biopharmaceutical company Amplifica Holdings Group, Inc. to develop an innovative treatment to address androgenic alopecia.
Amplifica has partnered with Ingenza to advance the development of its signalling molecules
